Q32 Bio Inc.
3.11
0.04 (1.30%)
At close: Jan 15, 2025, 12:56 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio -0.31 -1.69 -5.36 -4.03 -8.39 -11.49 -23.29 -86.8
PS Ratio 30.41 10.87 5.92 191.83 523.31 119.96 n/a n/a
PB Ratio 0.48 -0.55 -2.26 2.64 3.37 3.25 7.10 93.12
P/FCF Ratio -0.36 -5.38 -6.07 -5.29 -7.7 -9.46 154.50 -66.69
P/OCF Ratio -0.37 -6.6 -6.1 -5.49 -9.54 -15 107.81 -82.33
OCF/S Ratio -83.24 -1.65 -0.97 -34.91 -54.84 -8 n/a n/a
Debt / Equity Ratio 0.02 -0.34 -0.06 0.08 n/a n/a n/a n/a
Quick Ratio 7.25 0.78 4.60 9.69 21.54 9.84 14.85 1.88
Current Ratio 7.25 0.81 4.71 9.69 21.54 9.84 14.85 1.88
Asset Turnover 0.00 0.11 0.97 0.01 0.01 0.02 n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -1.55 0.33 0.42 -0.66 -0.4 -0.28 -0.31 -1.07
Return on Assets (ROA) -0.37 -0.69 -1.07 -0.49 -0.33 -0.21 -0.22 -0.57
Return on Capital (ROIC) -0.31 -10.03 -1.31 -0.54 -0.37 -0.25 -0.23 -1.28
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 50.00% 60.92% 71.91% 100.00% 100.00% 100.00% n/a n/a
Net Profit Margin -9.77K% -643.65% -110.58% -4.76K% -6.24K% -1.04K% n/a n/a
Pretax Profit Margin -7.53K% -642.72% -108.97% -4.76K% -6.24K% -1.04K% n/a n/a
Operating Profit Margin -7.97K% -589.76% -108.01% -4.82K% -6.60K% -1.13K% n/a n/a
FCF Margin -8.34K% -202.1% -97.54% -3.63K% -6.79K% -1.27K% n/a n/a
EBITDA Margin -7.48K% -584.2% -253.8% -4.49K% -6.22K% -1.10K% n/a n/a